Long-term outcomes of sofosbuvir (SOF) for the treatment of chronic hepatitis C infected (CHC) patients

被引：0
|
作者：
Cure, Sandrine [1 ]
Guerra, Ines [1 ]
Granzow, Henrike [1 ]
Dusheiko, Geoffrey M. [2 ]
机构：
[1] OptumInsight, HEOR, Uxbridge, Middx, England
[2] Royal Free Hosp, UCL Inst Liver & Digest Hlth, London NW3 2QG, England
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1107
引用
收藏
页码：747A / 747A
页数：1
相关论文
共 50 条
  • [1] LONG-TERM OUTCOMES OF SOFOSBUVIR (SOF) FOR THE TREATMENT OF CHRONIC HEPATITIS C INFECTED (CHC) PATIENTS
    Cure, S.
    Guerra, I
    Dusheiko, G.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A357 - A357
  • [2] LONG-TERM OUTCOMES OF LEDIPASVIR/SOFOSBUVIR (LDV/ SOF) FOR THE TREATMENT OF CHRONIC HEPATITIS C INFECTED (HCV) GENOTYPE 1 PATIENTS IN THE UK
    Guerra, I
    Marie, L.
    Cure, S.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A675 - A675
  • [3] LONG-TERM OUTCOMES ASSOCIATED WITH SOFOSBUVIR-BASED REGIMENS FOR TREATMENT OF CHRONIC HEPATITIS C IN CHINA
    Tang, H.
    Wu, J.
    Wu, B.
    Xu, X.
    Ye, X.
    Zhang, W.
    [J]. VALUE IN HEALTH, 2018, 21 : S65 - S65
  • [4] COST-EFFECTIVENESS AND LONG-TERM OUTCOMES OF SOVALDI (SOFOSBUVIR) FOR THE TREATMENT OF CHRONIC HEPATITIS C INFECTED (HCV) PATIENTS FROM A SWEDISH SOCIETAL PERSPECTIVE
    Cure, S.
    Guerra, I
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A675 - A675
  • [5] Treatment and Outcomes of Chronic Hepatitis C (CHC) in the Elderly
    El-Serag, Hashem B.
    Duan Zhigang
    Kramer, Jennifer R.
    Kanwal, Fasiha
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S1096 - S1096
  • [6] Successful Treatment with Sofosbuvir (SOF) Regimen Improves Patient-reported Outcomes (PROs) in Patients with Chronic Hepatitis C (CH-C)
    Younossi, Zobair
    Stepanova, Maria
    Gerber, Lynn
    Lawitz, Eric
    Nelson, David
    Nader, Fatema
    Hunt, Sharon
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S144 - S144
  • [7] SAFETY AND EFFICACY OF SOFOSBUVIR/VELPATASVIR (SOF/VEL) IN PEDIATRIC PATIENTS 6 TO < 18 YEARS OLD WITH CHRONIC HEPATITIS C (CHC) INFECTION
    Jonas, Maureen
    Romero, Rene
    Sokal, Etienne
    Rosenthal, Philip
    Verucchi, Gabriella
    Lin, Chuan-Hao
    Wen, Jessica
    Narkewicz, Michael
    Bansal, Sanjay
    Shao, Jiang
    Hsueh, Sean
    Gaggar, Anuj
    Kersey, Kathryn
    Chan, Carol Yee Kwan
    Gonzalez-Peralta, Regino
    Leung, Daniel
    Balistreri, William
    Murray, Karen
    Schwarz, Kathleen
    [J]. GUT, 2020, 69 : A74 - A74
  • [8] Evaluation of the Long-Term Health Outcomes of Ledipasivir/Sofosbuvir (LDV/SOF) and Sofosbuvir-based Regimens for Patients With Chronic Hepatitis C (CHC) And Liver Cirrhosis Across Genotypes 1 to 4 (GT 1-4): Results from a Decision-Analytic Markov Model
    Gordon, Stuart C.
    Ahmed, Aijaz
    Saab, Sammy
    Younossi, Zobair
    [J]. HEPATOLOGY, 2014, 60 : 1040A - 1041A
  • [9] long-term follow up of chronic hepatitis C Egyptian patients treated with sofosbuvir/daclatasvir regimen
    Elnoemany, Karim
    Badr, Mohamed
    Elnadry, Mohamed
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 137 - 137
  • [10] Cost-effectiveness of sofosbuvir for the treatment of chronic hepatitis C-infected patients
    Cure, S.
    Guerra, I.
    Dusheiko, G.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2015, 22 (11) : 882 - 889
12345